Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The grouping of PorA, factor H binding protein (fHbp), Neisserial adhesin A (NadA), and Neisserial heparin binding antigen (NHBA) as a single target is incorrect. While all are distinct, major outer membrane proteins from Neisseria meningitidis with significant roles in pathogenesis and as vaccine targets, they do not form a single molecular entity. Each possesses unique sequence, structure, and function. The initial query incorrectly combines these separate, well-characterized antigens into one conceptual target. Each component (PorA, fHbp, NadA, and NHBA) is a separate and specific surface antigen on Neisseria meningitidis, critical for virulence and as components in modern meningococcal vaccines, but they are not a single molecular target. Details for each are provided independently in the source material; for accurate data structuring, they should be treated as distinct targets.
Vaccines containing PorA elicit antibodies, which induce complement-mediated killing of N. meningitidis; Antibody recognition of PorA variable regions triggers bactericidal activity; Elicits protective antibodies that block fHbp binding to factor H, allowing complement-mediated killing; Elicits antibodies that prevent colonization and invasion; Induces protective antibodies.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neisserial heparin binding antigen, Neisserial adhesin A, factor H binding protein, and PorA (Combined Meningococcal Vaccine Antigens).